ZJAMP.(SZ:002758)2023-04-28 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥10,211,322,413.10, representing a year-on-year increase of 7.83% compared to ¥9,469,580,257.41 in the same period last year[3] - The net profit attributable to shareholders for Q1 2023 was ¥91,108,881.34, a decrease of 34.73% from ¥139,944,505.03 in the previous year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥76,817,931.44, down 39.29% from ¥126,972,158.89 year-on-year[3] - Basic earnings per share for Q1 2023 were ¥0.18, down 35.71% from ¥0.29 in the same period last year[4] - Net profit for Q1 2023 was CNY 183,495,718.88, down 33.6% from CNY 276,234,305.42 in Q1 2022[19] - Operating profit for Q1 2023 was CNY 239,340,641.20, a decrease of 31.6% compared to CNY 350,236,233.75 in Q1 2022[19] - Total comprehensive income for Q1 2023 was CNY 179,453,812.03, down from CNY 263,075,908.10 in Q1 2022[20] - Basic and diluted earnings per share for Q1 2023 were both CNY 0.18, compared to CNY 0.28 in Q1 2022[20] Cash Flow and Assets - The net cash flow from operating activities decreased significantly by 99.37%, amounting to ¥8,281,223.74 compared to ¥1,321,774,181.34 in the previous year[4] - Cash and cash equivalents at the end of Q1 2023 amounted to CNY 5,650,265,454.12, up from CNY 5,573,814,417.06 at the beginning of the year, reflecting a growth of 1.4%[15] - Cash flow from operating activities generated a net amount of CNY 8,281,223.74, significantly lower than CNY 1,321,321,047.70 in the same period last year[22] - Investment activities resulted in a net cash outflow of CNY 4,209,748.71, compared to a net inflow of CNY 10,915,042.95 in the previous year[22] - Financing activities generated a net cash inflow of CNY 280,077,405.24, up from CNY 121,689,859.62 in Q1 2022[22] - Total assets at the end of Q1 2023 were ¥18,638,733,408.29, a decrease of 4.44% from ¥19,504,435,834.63 at the end of the previous year[4] - Total assets decreased to CNY 18,638,733,408.29 from CNY 19,604,145,837.71, indicating a decline of 4.9%[16] - Cash and cash equivalents at the end of Q1 2023 amounted to CNY 3,963,050,453.12, an increase from CNY 3,580,727,757.24 at the end of Q1 2022[22] Liabilities and Equity - The total liabilities decreased to CNY 11,684,968,231.03 from CNY 13,034,935,596.82, a reduction of 10.4%[16] - The company's total equity increased to CNY 6,953,765,177.26 from CNY 6,569,210,240.89, representing a growth of 5.8%[16] - The company's short-term borrowings rose to CNY 2,527,690,854.93 from CNY 2,415,301,268.43, an increase of 4.6%[16] - The company reported a decrease in employee compensation payable to CNY 280,278,014.19 from CNY 379,106,372.30, a decline of 26.1%[16] Operational Insights - The agricultural comprehensive service business maintained rapid revenue growth despite a downturn in agricultural product prices[8] - The automotive trading service business experienced a decline in revenue and profit due to various market pressures, but the company focused on high-end brands to mitigate impacts[8] - The company aims to explore a full industry chain model for traditional Chinese medicine to promote high-quality development in the sector[9] - The company plans to accelerate digital platform construction and enhance management efficiency in response to market changes[9] Research and Development - Research and development expenses increased to CNY 4,991,112.61, up 49.6% from CNY 3,339,105.25 in the previous year[19] Accounting Changes - The company implemented new accounting standards starting January 1, 2023, affecting the financial statements[23] Other Financial Adjustments - Deferred tax assets increased from ¥91,279,552.06 to ¥190,989,555.14, a change of ¥99,710,003.08[24] - Non-current assets rose from ¥4,099,778,027.58 to ¥4,199,488,030.66, reflecting an increase of ¥99,710,003.08[24] - Total liabilities rose from ¥12,935,225,593.74 to ¥13,034,935,596.82, reflecting an increase of ¥99,710,003.08[24] - The first quarter report was not audited[25]